UroGen Pharma Ltd (URGN): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 60 US Dollar | 6 | 1 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 48.880.564 | 11,7 | 5,87 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name UroGen Pharma Ltd
Mitarbeiter 300
Handelsplatz NASDAQ
Ticker Symbol URGN
IPO Datum 2017-05-04
Adresse 400 Alexander Park Drive, Princeton, NJ, United States, 08540
Webseite https://www.urogen.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Elizabeth A. Barrett | President, CEO & Director |
| 2 | Mr. Jason Drew Smith J.D. | General Counsel, Chief Compliance Officer & Corporate Secretary |
| 3 | Dr. Mark P. Schoenberg M.D. | Chief Medical Officer |
| 4 | Mr. Christopher Degnan CPA | Chief Financial Officer |
| 5 | Mr. Vincent I. Perrone | Senior Director of Investor Relations |
| 6 | Ms. Alison Hardgrove | Senior Vice President of Human Resources |
| 7 | Dr. Marina Konorty Ph.D. | Executive Vice President of Research & Development and Technical Operations |
| 8 | Mr. James Ottinger R.ph. | Executive Vice President of Regulatory Affairs & Quality |
| 9 | Mr. Michael J. Louie M.D., M.P.H., M.Sc. | Chief Development Officer |
| 10 | Mr. Timothy Simon | Senior Vice President of Business Development & Portfolio Strategy |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RTW INVESTMENTS, LLC | 9,30% | 0,15 Mrd. USD |
| 2 | BlackRock Inc | 6,55% | 0,11 Mrd. USD |
| 3 | Morgan Stanley - Brokerage Accounts | 5,27% | 0,09 Mrd. USD |
| 4 | Kynam Capital Management, LP | 4,98% | 0,08 Mrd. USD |
| 5 | Jefferies Financial Group Inc | 4,50% | 0,07 Mrd. USD |
| 6 | SG Americas Securities, LLC | 4,20% | 0,07 Mrd. USD |
| 7 | American Century Companies Inc | 3,45% | 0,06 Mrd. USD |
| 8 | Point72 Asset Management, L.P. | 3,12% | 0,05 Mrd. USD |
| 9 | Frontier Capital Management CO Inc | 3,09% | 0,05 Mrd. USD |
| 10 | Opaleye Management Inc | 2,95% | 0,05 Mrd. USD |
| 11 | SILVERARC CAPITAL MANAGEMENT, LLC | 2,66% | 0,04 Mrd. USD |
| 12 | MENORA MIVTACHIM HOLDINGS LIMITED | 2,36% | 0,04 Mrd. USD |
| 13 | D. E. Shaw & Co LP | 2,34% | 0,04 Mrd. USD |
| 14 | State Street Corp | 2,05% | 0,03 Mrd. USD |
| 15 | MPM Oncology Impact Management LP | 1,91% | 0,03 Mrd. USD |
| 16 | Soleus Capital Management, L.P. | 1,70% | 0,03 Mrd. USD |
| 17 | The Goldman Sachs Group Inc | 1,68% | 0,03 Mrd. USD |
| 18 | Migdal Insurance & Financial Holdings Ltd | 1,58% | 0,03 Mrd. USD |
| 19 | Orbimed Advisors LLC | 1,38% | 0,02 Mrd. USD |
| 20 | Geode Capital Management, LLC | 1,25% | 0,02 Mrd. USD |